We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

20 hedge funds and large institutions have $5.82M invested in Sophiris Bio, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

687% more capital invested

Capital invested by funds: $739K → $5.82M (+$5.08M)

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

43% more funds holding

Funds holding: 1420 (+6)

5.16% less ownership

Funds ownership: 5.16%0% (-5.2%)

Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
6
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

SPHS Hedge Fund Activity: Q4 2015 in Review

20 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2015, worth a combined $5.82M — up 687% from $739K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SPHS positions and 2 closed out — a net gain of 6 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $930K. The largest seller was Royal Bank of Canada, cutting an estimated $12.4K.

  • 20 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2015, up from 14 in Q3 2015.
  • Funds reported $5.82M of Sophiris Bio, Inc. stock for Q4 2015, up 687% quarter-over-quarter.
  • 8 funds opened new Sophiris Bio, Inc. positions in Q4 2015 and 2 closed out, a net change of +6 holders.
  • The largest Sophiris Bio, Inc. buyer in Q4 2015 was Rock Springs Capital Management, an estimated $930K added.
  • The largest Sophiris Bio, Inc. seller in Q4 2015 was Royal Bank of Canada, an estimated $12.4K sold.

Based on aggregated 13F filings for Q4 2015.